Access to Guideline Concordant Care for Node-Positive Non-Small Cell Lung Cancer in the United States-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Access to Guideline Concordant Care for Node-Positive Non-Small Cell Lung Cancer in the United States

Published:2023-11 Issue: Volume: Page:
ISSN:0003-4975
Container-title:The Annals of Thoracic Surgery
language:en
Short-container-title:The Annals of Thoracic Surgery

Author:

Collins Micaela L.,Mack Shale J.,Whitehorn Gregory L.,Till Brian M.,Grenda Tyler R.,Evans Nathaniel R.,Gordon Sarah W.,Okusanya Olugbenga T.

Funder

AstraZeneca

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference19 articles.

1. U.S. Cancer Statistics Lung Cancer Stat Bite,2022

2. Disparities in guideline-concordant treatment for pathologic N1 non-small cell lung cancer;Toubat;Ann Thorac Surg,2020

3. Disparities in receiving guideline-concordant treatment for lung cancer in the United States;Blom;Ann Am Thorac Soc,2020

4. Guideline-concordant care improves overall survival for locally advanced non-small-cell lung carcinoma patients: a National Cancer Database analysis;Ahmed;Clin Lung Cancer,2017

5. Disparities in guideline-concordant treatment for node-positive, non-small cell lung cancer following surgery;Farrow;J Thorac Cardiovasc Surg,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP